Article
Treatment of dyskeratosis congenita-associated pulmonary fibrosis with danazol.
Pediatric pulmonology - 1 Dec 2015
Zlateska Bozana, Ciccolini Amanda, Dror Yigal
Abstract excerpt
Individuals with Dyskeratosis Congenita (DC) are at increased risk for complications in variety of systems including pulmonary fibrosis. Idiopathic and DC-associated pulmonary fibrosis are progressive and fatal disorders without known treatment. Here we describe, for the first time, marked improvement in the clinical and laboratory parameters of the pulmonary disease of a child who suffered from TINF2-associated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
